'Molecular glue' redirects a cancer-driving protein to activate cell death

A two-headed molecule designed by Stanford Medicine researchers hijacks one of the most common protein drivers of B-cell lymphoma, flipping it from its role as a promoter of cell growth into an arbiter of cell death. In mice, a short course of twice-daily treatment eliminated aggressive lymphoma tumors within 11 days.

Read it at Medical Xpress ↗

← Front page